Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AMNEAL PHARMACEUTICALS, INC - 16 Year Stock Price History | AMRX

Historical daily share price chart and data for AMNEAL PHARMACEUTICALS, INC since 2009 adjusted for splits and dividends. The latest closing stock price for AMNEAL PHARMACEUTICALS, INC as of May 29, 2025 is 7.30.
  • The all-time high AMNEAL PHARMACEUTICALS, INC stock closing price was 51.31 on April 15, 2015.
  • The AMNEAL PHARMACEUTICALS, INC 52-week high stock price is 9.47, which is 29.7% above the current share price.
  • The AMNEAL PHARMACEUTICALS, INC 52-week low stock price is 6.29, which is 13.8% below the current share price.
  • The average AMNEAL PHARMACEUTICALS, INC stock price for the last 52 weeks is 7.94.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
AMNEAL PHARMACEUTICALS, INC Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 7.9694 7.7600 9.0100 6.9700 7.3000 -7.83%
2024 7.0687 5.9800 9.2500 5.2400 7.9200 30.48%
2023 3.0844 2.1100 6.2100 1.2700 6.0700 205.03%
2022 3.2659 4.8500 4.8900 1.9600 1.9900 -58.46%
2021 5.3073 4.8800 7.3800 3.9500 4.7900 4.81%
2020 4.2661 4.7700 5.4600 2.4600 4.5700 -5.19%
2019 7.5244 14.1000 14.8400 2.2900 4.8200 -64.38%
2018 19.2110 17.6000 24.2700 13.0900 13.5300 -18.74%
2017 16.0902 13.5500 23.8000 8.0000 16.6500 25.66%
2016 27.8875 42.2700 42.6500 12.7500 13.2500 -69.01%
2015 43.0850 31.8000 51.3100 30.2000 42.7600 34.97%
2014 26.7322 24.8200 32.7500 22.0200 31.6800 26.01%
2013 19.9442 20.6600 25.1400 14.8000 25.1400 22.69%
2012 22.4247 20.4700 27.0200 18.6400 20.4900 1.59%
2011 21.5566 21.0800 28.7300 15.2600 20.1700 0.30%
2010 17.9160 14.0900 21.8600 13.0000 20.1100 47.76%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.260B $2.794B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.007B 31.89
Zoetis (ZTS) United States $73.637B 27.48
Daiichi Sankyo, - (DSNKY) Japan $51.945B 26.43
Takeda Pharmaceutical (TAK) Japan $46.424B 9.23
Sandoz Group AG (SDZNY) Switzerland $21.498B 0.00
Summit Therapeutics (SMMT) United States $19.339B 0.00
Merck (MKKGY) Germany $16.886B 12.37
United Therapeutics (UTHR) United States $14.237B 12.60
Shionogi (SGIOY) Japan $13.900B 13.93
Neurocrine Biosciences (NBIX) United States $12.176B 41.71
IPSEN (IPSEY) France $9.821B 0.00
Orion OYJ (ORINY) Finland $9.318B 25.20
Corcept Therapeutics (CORT) United States $8.234B 66.94
Stevanato Group S.p.A (STVN) Italy $7.023B 42.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.014B 0.00
Grifols, S.A (GRFS) Spain $5.624B 0.00
Ionis Pharmaceuticals (IONS) United States $5.162B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.818B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.993B 10.49
Crinetics Pharmaceuticals (CRNX) United States $2.800B 0.00
Hypermarcas (HYPMY) Brazil $2.707B 17.81
BioCryst Pharmaceuticals (BCRX) United States $2.210B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.943B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.787B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.730B 0.00
Indivior (INDV) United States $1.660B 7.04
ARS Pharmaceuticals (SPRY) United States $1.458B 0.00
Evotec AG (EVO) Germany $1.406B 0.00
Guardian Pharmacy Services (GRDN) United States $1.358B 0.00
Dyne Therapeutics (DYN) United States $1.337B 0.00
Ocular Therapeutix (OCUL) United States $1.257B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.078B 21.57
Harrow (HROW) United States $0.951B 0.00
Ardelyx (ARDX) United States $0.935B 0.00
Collegium Pharmaceutical (COLL) United States $0.929B 5.01
Avadel Pharmaceuticals (AVDL) Ireland $0.875B 0.00
Enliven Therapeutics (ELVN) United States $0.789B 0.00
Cronos Group (CRON) Canada $0.779B 0.00
Akebia Therapeutics (AKBA) United States $0.756B 0.00
Xeris Biopharma Holdings (XERS) United States $0.748B 0.00
AleAnna (ANNA) United States $0.601B 0.00
Elite Pharmaceuticals (ELTP) United States $0.575B 0.00
KalVista Pharmaceuticals (KALV) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.553B 12.02
Regulus Therapeutics (RGLS) United States $0.549B 0.00
Xencor (XNCR) United States $0.537B 0.00
Bioventus (BVS) United States $0.536B 13.60
Relay Therapeutics (RLAY) United States $0.506B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.458B 0.00
Zevra Therapeutics (ZVRA) United States $0.455B 0.00
Altimmune (ALT) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.435B 9.09
Oruka Therapeutics (ORKA) United States $0.429B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.427B 0.00
CytoDyn (CYDY) United States $0.421B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Verve Therapeutics (VERV) United States $0.378B 0.00
Savara (SVRA) United States $0.369B 0.00
Organogenesis (ORGO) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.343B 9.27
Heron Therapeutics (HRTX) United States $0.279B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.271B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.88
MediWound (MDWD) Israel $0.228B 0.00
ProKidney (PROK) United States $0.207B 0.00
Nanobiotix S.A (NBTX) France $0.189B 0.00
Journey Medical (DERM) United States $0.183B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Esperion Therapeutics (ESPR) United States $0.165B 0.00
Avita Medical (RCEL) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
4D Molecular Therapeutics (FDMT) United States $0.161B 0.00
OmniAb (OABI) United States $0.158B 0.00
Profound Medical (PROF) Canada $0.157B 0.00
Aclaris Therapeutics (ACRS) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.133B 0.00
Nektar Therapeutics (NKTR) United States $0.130B 0.00
Larimar Therapeutics (LRMR) United States $0.127B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Liminatus Pharma (LIMN) $0.119B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.106B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.096B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Lexeo Therapeutics (LXEO) United States $0.091B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 64.89
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Inotiv (NOTV) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.59
Galectin Therapeutics (GALT) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Surrozen (SRZN) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Rafael Holdings (RFL) United States $0.032B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
PolyPid (PYPD) Israel $0.026B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
SHINECO (SISI) China $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00